These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37611483)

  • 1. Driving impairment and altered ocular activity under the effects of alprazolam and alcohol: A randomized, double-blind, placebo-controlled study.
    Aitken B; Hayley AC; Ford TC; Geier L; Shiferaw BA; Downey LA
    Drug Alcohol Depend; 2023 Oct; 251():110919. PubMed ID: 37611483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of alcohol intoxication on driving performance, confidence in driving ability, and psychomotor function: a randomized, double-blind, placebo-controlled study.
    Garrisson H; Scholey A; Verster JC; Shiferaw B; Benson S
    Psychopharmacology (Berl); 2022 Dec; 239(12):3893-3902. PubMed ID: 36322184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the influence of 0.03%, 0.05% and 0.08% blood alcohol concentrations on lane positioning and steering control of Indian drivers.
    Yadav AK; Velaga NR
    Traffic Inj Prev; 2021; 22(5):343-348. PubMed ID: 33979247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute administration of alprazolam, alcohol and their combination on cognitive performance and mood: A randomised, double-blind, placebo-controlled study.
    Aitken B; Hayley AC; Ford TC; Geier L; Shiferaw BA; Downey LA
    J Psychopharmacol; 2023 Dec; 37(12):1227-1237. PubMed ID: 37724443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of simulated driving in comparison to laboratory-based tests to assess the pharmacodynamics of alprazolam and alcohol.
    Huizinga CR; Zuiker RG; de Kam ML; Ziagkos D; Kuipers J; Mejia Y; van Gerven JM; Cohen AF
    J Psychopharmacol; 2019 Jul; 33(7):791-800. PubMed ID: 30912701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alcohol at 0.05% blood alcohol concentration (BAC) on low speed urban driving.
    Brown TL; Lee JD; Fiorentino D
    Traffic Inj Prev; 2018; 19(sup2):S175-S177. PubMed ID: 30841807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled study.
    Verster JC; Volkerts ER; Verbaten MN
    Neuropsychopharmacology; 2002 Aug; 27(2):260-9. PubMed ID: 12093599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaze entropy measures detect alcohol-induced driver impairment.
    Shiferaw BA; Crewther DP; Downey LA
    Drug Alcohol Depend; 2019 Nov; 204():107519. PubMed ID: 31479863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using alcohol intoxication goggles (Fatal Vision® goggles) to detect alcohol related impairment in simulated driving.
    McCartney D; Desbrow B; Irwin C
    Traffic Inj Prev; 2017 Jan; 18(1):19-27. PubMed ID: 27260944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of CannEpil
    Manning B; Hayley AC; Catchlove S; Shiferaw B; Stough C; Downey LA
    J Psychopharmacol; 2023 May; 37(5):472-483. PubMed ID: 37129083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator.
    Weiler JM; Bloomfield JR; Woodworth GG; Grant AR; Layton TA; Brown TL; McKenzie DR; Baker TW; Watson GS
    Ann Intern Med; 2000 Mar; 132(5):354-63. PubMed ID: 10691585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International policies on alcohol impaired driving: are legal blood alcohol concentration (BAC) limits in motorized countries compatible with the scientific evidence?
    Desapriya EB; Iwase N; Brussoni M; Shimizu S; Belayneh TN
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Apr; 38(2):83-102. PubMed ID: 12784660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory analysis of risky driving at 0.05% and 0.08% blood alcohol concentration.
    Van Dyke NA; Fillmore MT
    Drug Alcohol Depend; 2017 Jun; 175():127-132. PubMed ID: 28412303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating drugged driving: Effects of exemplar pain and anxiety medications.
    Brown TL; Milavetz G; Gaffney G; Spurgin A
    Traffic Inj Prev; 2018 Feb; 19(sup1):S97-S103. PubMed ID: 29584496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleepiness combined with low alcohol intake in women drivers: greater impairment but better perception than men?
    Barrett PR; Horne JA; Reyner LA
    Sleep; 2004 Sep; 27(6):1057-62. PubMed ID: 15532198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Police documentation of alcohol involvement in hospitalized injured drivers.
    Brubacher JR; Chan H; Fang M; Brown D; Purssell R
    Traffic Inj Prev; 2013; 14(5):453-60. PubMed ID: 23683066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild to moderate dehydration combined with moderate alcohol consumption has no influence on simulated driving performance.
    Irwin C; Leveritt M; Shum DH; Desbrow B
    Traffic Inj Prev; 2014; 15(6):652-62. PubMed ID: 24867575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of alcohol use on accelerating and braking behaviors of drivers.
    Yadav AK; Velaga NR
    Traffic Inj Prev; 2019; 20(4):353-358. PubMed ID: 31039040
    [No Abstract]   [Full Text] [Related]  

  • 19. A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car.
    Ridout F; Shamsi Z; Meadows R; Johnson S; Hindmarch I
    Clin Ther; 2003 May; 25(5):1518-38. PubMed ID: 12867226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg.
    Leufkens TR; Vermeeren A; Smink BE; van Ruitenbeek P; Ramaekers JG
    Psychopharmacology (Berl); 2007 May; 191(4):951-9. PubMed ID: 17219217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.